Spike (B.1.429 Variant) Pseudotyped
![Research Use Only](static/images/certificates/ruo.jpg)
78172
![BPS Bioscience](https://www.bio-connect.nl/wp-content/uploads/2024/03/BPS_logo.png)
Product group Expression
Overview
- SupplierBPS Bioscience
- Product NameSpike (B.1.429 Variant) Pseudotyped
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionThe Spike (B.1.429 Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 B.1.429 Variant Spike (Genbank Accession #QHD43416.1 with B.1.429 variant mutations; see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (B.1.429 Variant) (SARS-CoV-2) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 B.1.429 variant in a Biosafety Level 2 facility. Spike Mutations in B.1.429 Variant: S13I W152C L452R D614G
- Storage Instruction-80°C
- UNSPSC41106618